SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-19-000813
Filing Date
2019-08-14
Accepted
2019-08-14 07:36:37
Documents
67
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT htbx_10q.htm 10-Q 586860
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex31z1.htm EX-31.1 11819
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex31z2.htm EX-31.2 11870
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex32z1.htm EX-32.1 4799
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex32z2.htm EX-32.2 4784
  Complete submission text file 0001553350-19-000813.txt   3192129

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE htbx-20190630.xml EX-101.INS 487568
7 XBRL SCHEMA FILE htbx-20190630.xsd EX-101.SCH 39035
8 XBRL CALCULATION FILE htbx-20190630_cal.xml EX-101.CAL 67483
9 XBRL DEFINITION FILE htbx-20190630_def.xml EX-101.DEF 107662
10 XBRL LABEL FILE htbx-20190630_lab.xml EX-101.LAB 320580
11 XBRL PRESENTATION FILE htbx-20190630_pre.xml EX-101.PRE 238430
Mailing Address 801 CAPITOLA DRIVE DURHAM NC 27713
Business Address 801 CAPITOLA DRIVE DURHAM NC 27713 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 191022822
SIC: 2834 Pharmaceutical Preparations